We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The EV industry in 2024 is poised at a critical juncture, with growth opportunities tempered by economic and technological challenges. However, the slowing momentum should gain traction in the medium term.
The group's performance as a whole has been remarkable over the last year, leading the market. But two of the members have seen their shares slack, raising questions surrounding their status in the elite club. Should they be kicked out?
As the EV price war continues and consumer preferences shift toward more affordable options, Ford's (F) strategic pricing moves could help bolster its market share.
Toyota (TM) expects fiscal 2024 operating income to be 4.9 trillion yen, up from the previous forecast of 4.5 trillion yen and indicating a surge of 79.8% year over year.
electric-vehicles: Archive
Ford (F) Agrees to Pay $365M to Settle Tariff Act Breach
by Zacks Equity Research
Ford (F) agrees to pay $365 million to settle the violation of the Tariff Act and move on from the intricate and decade-long dispute.
FPositive Net Change TMNegative Net Change ALSNNegative Net Change MODNegative Net Change
auto-tires-trucks electric-vehicles
Pain or Gain Ahead of Electric Vehicle ETFs?
by Sanghamitra Saha
The EV industry in 2024 is poised at a critical juncture, with growth opportunities tempered by economic and technological challenges. However, the slowing momentum should gain traction in the medium term.
FPositive Net Change DRIVNegative Net Change GMNegative Net Change TSLANegative Net Change CARZNegative Net Change KARSNegative Net Change IDRVNegative Net Change
electric-vehicles etfs
After Golden Cross, Ryan Specialty Group (RYAN)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RYANPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
General Motors (GM) Resumes Chevy Blazer EV Sales, Cuts Price
by Zacks Equity Research
General Motors (GM) reduces the price and resumes the sales of the Chevy Blazer EV following a halt in deliveries to address software issues.
TMNegative Net Change GMNegative Net Change ALSNNegative Net Change MODNegative Net Change
auto-tires-trucks electric-vehicles
Rivian (RIVN) Unveils R2, R3 & R3X With New Midsize Platform
by Zacks Equity Research
Rivian's (RIVN) R2, R3 and R3X are built on an efficient all-new midsize vehicle platform.
GMNegative Net Change ALSNNegative Net Change MODNegative Net Change RIVNNegative Net Change
auto-tires-trucks electric-vehicles
Do These 2 Stocks Belong in the Magnificent 7?
by Derek Lewis
The group's performance as a whole has been remarkable over the last year, leading the market. But two of the members have seen their shares slack, raising questions surrounding their status in the elite club. Should they be kicked out?
AMZNNegative Net Change AAPLNegative Net Change MSFTNegative Net Change NVDANegative Net Change TSLANegative Net Change GOOGLNegative Net Change METANegative Net Change
advertising auto-tires-trucks electric-vehicles semiconductor tech-stocks
Should You Buy Gossamer Bio (GOSS) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
GOSSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
3 Top Ranked Stocks with Bargain Valuations
by Ethan Feller
Investors who buy stocks trading below historic valuations enjoy a certain confidence that growth investors often have to swallow
HMCNegative Net Change KKRNegative Net Change TSLANegative Net Change PERINegative Net Change
ad-tech auto-tires-trucks electric-vehicles finance
Allogene Therapeutics (ALLO)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
ALLOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Ford (F) Reports U.S. Sales Growth of 10.5% Y/Y in February
by Zacks Equity Research
Ford's (F) U.S. sales in February increase 10.5% year over year, making the automaker the No. 1 seller in America for two consecutive months.
FPositive Net Change TMNegative Net Change HMCNegative Net Change
auto-tires-trucks electric-vehicles
AXT (AXTI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AXTINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Lancaster Colony (LANC)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
LANCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Wynn Resorts (WYNN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
WYNNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Tenaya Therapeutics, Inc. (TNYA) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
TNYAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Sanmina (SANM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
SANMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Ford (F) Slashes 2023 Mustang Mach-E Prices to Boost Sales
by Zacks Equity Research
As the EV price war continues and consumer preferences shift toward more affordable options, Ford's (F) strategic pricing moves could help bolster its market share.
FPositive Net Change PCARNegative Net Change GMNegative Net Change TSLANegative Net Change
auto-tires-trucks electric-vehicles
NVIDIA Beats & Raises in Q4; Late Trading +8%
by Mark Vickery
Typically, NVIDIA beat estimates on both top and bottom lines, seemingly without breaking a sweat.
AMDNegative Net Change NVDANegative Net Change SMCINegative Net Change ETSYNegative Net Change RIVNNegative Net Change
artificial-intelligence cryptocurrency e-commerce earnings electric-vehicles semiconductor tech-stocks
VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VXRTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Great Lakes Dredge & Dock (GLDD)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
GLDDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Cedar Fair, L.P. (FUN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FUNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
BrightSphere Investment Group (BSIG)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
BSIGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy CryoPort, Inc. (CYRX) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
CYRXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
General Motors (GM) Inks a $19B Deal for EV Battery Materials
by Zacks Equity Research
The $19 billion deal between General Motors (GM) and LG Chem represents a landmark moment in the evolution of the EV industry.
PCARNegative Net Change GTPositive Net Change GMNegative Net Change OSKPositive Net Change
auto-tires-trucks batteries electric-vehicles
Toyota (TM) Breezes Past Q3 Earnings Estimates, Lifts FY24 View
by Zacks Equity Research
Toyota (TM) expects fiscal 2024 operating income to be 4.9 trillion yen, up from the previous forecast of 4.5 trillion yen and indicating a surge of 79.8% year over year.
FPositive Net Change TMNegative Net Change GMNegative Net Change TSLANegative Net Change
auto-tires-trucks earnings electric-vehicles
Trip.com (TCOM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TCOMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines